6591 POSTER Improved 6-month Survival Rate in Subjects With Prostate Stem Cell Antigen (PSCA) Positive Tumours in a Global, Randomized Phase 2 Trial Comparing Gemcitabine Vs. Gemcitabine + Ags-1c4d4 (asp6182) in Metastatic Pancreatic Cancer (mPC)
Year: 2011
Type: article
Source: European Journal of Cancer
Authors: B.M. Wolpin, E.M. O'Reilly, Y.J. Ko, M.S. Rocha Lima, J.L. Spratlin, T. Macarulla, D. Pezet, A. Hartford, L.S. Jackson, M. Hidalgo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2010222595